STAA
STAAR Surgical Company
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$23.47
−0.45%Sep 2, 2026, 20:01 UTC
STAAR Surgical announced the appointment of Ben Park as Chief Technology Officer, effective immediately.
Source:Aug 14, 2026, 23:43 UTC
Staar Surgical Co shares rose 3.4% to $26.19 on August 14, 2026.
Source:Aug 12, 2026, 22:11 UTC
Staar Surgical reported Q2 2026 earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.21 per share, compared to a loss of $0.07 per share a year ago.
Aug 6, 2026, 00:00 UTC
STAAR Surgical Company appointed Warren Foust as President and Chief Executive Officer and member of the Board of Directors, effective August 4, 2026.
Source:Jul 17, 2026, 12:41 UTC
STAAR Surgical Company reported preliminary net sales for the second quarter of over $90 million, compared to $44.3 million a year ago.
Source:Jun 9, 2026, 00:00 UTC
STAAR Surgical appointed Deborah Andrews as interim Co-Chief Executive Officer and Chief Financial Officer, effective June 8, 2026, with a base salary of $575,000 and a bonus target of 60% of her base salary.